| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8531170 | International Immunopharmacology | 2018 | 7 Pages |
Abstract
Our findings indicated that the PD-1/PD-L1 interaction contributes to the immunosuppression in TSCC patients. ICIKs transfer is an effective therapy to reverse the immunosuppression caused by surgical procedures and chemotherapy and improve immune system function.
Keywords
PD-1OSCCPD-L1TSCCGMPHNSCCIRBPBMCsPFsprogression-free survivaloverall survivalGood Manufacturing PracticeTumour-infiltrating lymphocytesTILSperipheral blood mononuclear cellsChemotherapyinstitutional review boardoverall responseoral squamous cell carcinomatongue squamous cell carcinomaHead and neck squamous cell carcinoma
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Xiaofeng Huang, Jing Zhang, Xiaolong Li, Hongxing Huang, Ying Liu, Mei Yu, Yan Zhang, Hua Wang,